GB0127423D0 - Process - Google Patents

Process

Info

Publication number
GB0127423D0
GB0127423D0 GB0127423A GB0127423A GB0127423D0 GB 0127423 D0 GB0127423 D0 GB 0127423D0 GB 0127423 A GB0127423 A GB 0127423A GB 0127423 A GB0127423 A GB 0127423A GB 0127423 D0 GB0127423 D0 GB 0127423D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0127423A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0127423A priority Critical patent/GB0127423D0/en
Publication of GB0127423D0 publication Critical patent/GB0127423D0/en
Priority to AU2002365626A priority patent/AU2002365626A1/en
Priority to PCT/EP2002/012890 priority patent/WO2003048126A1/en
Ceased legal-status Critical Current

Links

GB0127423A 2001-11-15 2001-11-15 Process Ceased GB0127423D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GB0127423A GB0127423D0 (en) 2001-11-15 2001-11-15 Process
AU2002365626A AU2002365626A1 (en) 2001-11-15 2002-11-14 Process for the preparation of (2s)-3-(4-({(4-(aminocarbonyl)-1-piperidinyl)carbonyl}oxy) phenyl)2-{((2s)-4-methyl-2-{(2-(2-methylphenoxy)acetyl)amino}pentanoyl)amino(propanoic acid and intermediates therefore
PCT/EP2002/012890 WO2003048126A1 (en) 2001-11-15 2002-11-14 Process for the preparation of (2s)-3-[4-({[4-(aminocarbonyl)-1-piperidinyl]carbonyl}oxy) phenyl]2-{((2s)-4-methyl-2-{[2-(2-methylphenoxy)acetyl]amino}pentanoyl)amino[propanoic acid and intermediates therefore

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0127423A GB0127423D0 (en) 2001-11-15 2001-11-15 Process

Publications (1)

Publication Number Publication Date
GB0127423D0 true GB0127423D0 (en) 2002-01-09

Family

ID=9925826

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0127423A Ceased GB0127423D0 (en) 2001-11-15 2001-11-15 Process

Country Status (3)

Country Link
AU (1) AU2002365626A1 (en)
GB (1) GB0127423D0 (en)
WO (1) WO2003048126A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481397A1 (en) 2011-01-27 2012-08-01 Ratiopharm GmbH Pharmaceutical compositions comprising tasocitinib
EP2481411A1 (en) 2011-01-27 2012-08-01 Ratiopharm GmbH Oral dosage forms for modified release comprising the JAK3 inhibitor tasocitinib
EP2691395B1 (en) 2011-03-28 2017-08-30 ratiopharm GmbH Processes for preparing tofacitinib salts
WO2013090490A1 (en) 2011-12-15 2013-06-20 Ratiopharm Gmbh Tofacitinib salts
JP6041823B2 (en) 2013-03-16 2016-12-14 ファイザー・インク Tofacitinib oral sustained release dosage form
CN104356051A (en) * 2014-11-24 2015-02-18 苏州乔纳森新材料科技有限公司 Analgesic intermediate and synthesis method thereof
JP7189369B2 (en) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド Compounds for inhibition of alpha4beta7 integrin
US11116760B2 (en) 2018-10-30 2021-09-14 Gilead Sciences, Inc. Quinoline derivatives
JP7214882B2 (en) 2018-10-30 2023-01-30 ギリアード サイエンシーズ， インコーポレイテッド Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
JP7189368B2 (en) 2018-10-30 2022-12-13 ギリアード サイエンシーズ， インコーポレイテッド Compounds for inhibition of alpha4beta7 integrin
US11578069B2 (en) 2019-08-14 2023-02-14 Gilead Sciences, Inc. Compounds for inhibition of α4 β7 integrin
AU2021363705A1 (en) * 2020-10-21 2023-06-15 Azura Ophthalmics Ltd. Compounds and methods for the treatment of ocular disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9828074D0 (en) * 1998-12-18 1999-02-17 Glaxo Group Ltd Therapeutically useful compounds

Also Published As

Publication number Publication date
WO2003048126A1 (en) 2003-06-12
AU2002365626A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
GB0111020D0 (en) Process
GB0120835D0 (en) Process
GB0109555D0 (en) Process
GB0117144D0 (en) Process
GB0113645D0 (en) Process
GB0113789D0 (en) Process
GB0112792D0 (en) Process
GB0117090D0 (en) Process
GB0127423D0 (en) Process
GB0112801D0 (en) Process
GB0116212D0 (en) Process
GB0112331D0 (en) Process
GB2393678B (en) Cast-bonding process
GB0112789D0 (en) Process
GB0126768D0 (en) Novel process
GB0114033D0 (en) Process
GB0112327D0 (en) Process
GB0113370D0 (en) Process
GB0113922D0 (en) Process
GB0113772D0 (en) Process
GB0112794D0 (en) Process
GB0113641D0 (en) Process
GB0112787D0 (en) Process
GB0113787D0 (en) Process
GB0115839D0 (en) Process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)